Division of General Thoracic Surgery, Catholic University, Rome, Italy.
J Thorac Cardiovasc Surg. 2011 Mar;141(3):683-7. doi: 10.1016/j.jtcvs.2010.08.044. Epub 2010 Oct 13.
The use of small-bore wire-guided chest drains for pleural effusions and pneumothorax has become popular; however, limited data are available on its efficacy and morbidity. The aim of this retrospective study is to measure, via the analysis of the so far largest reported cohort, the efficacy, safety, and tolerability of this approach in different clinical conditions.
In the period from January 2002 to December 2008, 1092 patients have undergone the positioning of a small-bore wire-guided chest drain (12F) for the evidence of pneumothorax or pleural effusion and have been monitored over time for morbidity, pain at the time of insertion (measured via the visual analogue scale), and drain failure for misplacement or blockage. Patients with trauma were excluded from this study.
Male/female ratio and mean age were respectively 418:674 and 55.85 ± 18.6. Three-hundred ninety-nine (36.5%) drains were inserted for pneumothorax, 324 (29.7%) for malignant effusion, 97 (8.9%) for empyema, and 272 (24.9%) for nonmalignant effusion. The pain experience was on average "very mild" (mean visual analogue scale = 4.6 mm). The overall drain failure rate was 12.9%. The percentage of successful cases was 93.8% in malignant effusion, 93% in pneumothorax, and 92.3% in nonmalignant effusion; in the cases of pathologically diagnosed empyema, drains were more likely to get blocked (74.2%). We recorded 1 serious complication within the malignant effusion group.
Wire-guided 12F Seldinger-type drains are a well-tolerated and effective method of treating pneumothorax and uncomplicated pleural effusions (malignant and nonmalignant) with acceptable morbidity. The use of 12F small-bore chest drain is not indicated for the treatment of empyema.
小口径导丝引流管在胸腔积液和气胸中的应用已经变得很普遍;然而,其疗效和发病率的数据有限。本回顾性研究的目的是通过分析迄今为止最大的报告队列,来衡量这种方法在不同临床情况下的疗效、安全性和耐受性。
在 2002 年 1 月至 2008 年 12 月期间,1092 例患者接受了小口径导丝引流管(12F)的定位,用于气胸或胸腔积液的证据,并在一段时间内监测发病率、插入时的疼痛(通过视觉模拟量表测量)和引流管因位置不当或堵塞而失效的情况。本研究排除了创伤患者。
男女比例和平均年龄分别为 418:674 和 55.85±18.6。399 例(36.5%)引流管插入用于气胸,324 例(29.7%)用于恶性积液,97 例(8.9%)用于脓胸,272 例(24.9%)用于非恶性积液。平均疼痛体验为“非常轻微”(平均视觉模拟量表=4.6 毫米)。总体引流管失败率为 12.9%。恶性积液的成功率为 93.8%,气胸为 93%,非恶性积液为 92.3%;在病理诊断为脓胸的病例中,引流管更有可能堵塞(74.2%)。我们在恶性积液组记录了 1 例严重并发症。
导丝引导的 12F Seldinger 型引流管是一种耐受良好且有效的治疗气胸和简单胸腔积液(恶性和非恶性)的方法,发病率可接受。12F 小口径胸腔引流管不适用于治疗脓胸。